Digestive & Intestinal Remedies (Pharmacies) - Western Africa

  • Western Africa
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$178.50m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.01%, resulting in a market volume of US$250.50m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.43 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Western Africa is experiencing significant growth due to several factors. Customer preferences are shifting towards natural and herbal remedies, driving the demand for digestive and intestinal remedies. Additionally, the increasing prevalence of gastrointestinal disorders and the rising awareness about digestive health are contributing to the market's development.

Customer preferences:
Customers in Western Africa are increasingly seeking natural and herbal remedies for digestive and intestinal issues. This preference is driven by a growing awareness of the potential side effects of synthetic medications. Additionally, traditional medicine practices have a long history in the region, and many consumers trust the efficacy of natural remedies. As a result, there is a rising demand for herbal and plant-based digestive and intestinal remedies in the market.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Western Africa is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help restore the natural balance of bacteria in the gut and promote a healthy digestive system. Probiotics are increasingly being incorporated into various products, including yogurts, supplements, and drinks. This trend is driven by the rising awareness about the importance of gut health and the benefits of probiotics in maintaining a healthy digestive system. Another trend in the market is the increasing availability of over-the-counter digestive and intestinal remedies. Pharmacies in Western Africa are expanding their product offerings to cater to the growing demand for these remedies. This availability allows consumers to easily access and purchase the products they need without requiring a prescription. The convenience and accessibility of over-the-counter remedies are driving their popularity in the market.

Local special circumstances:
The market for Digestive & Intestinal Remedies in Western Africa is influenced by local cultural and dietary practices. The region has a diverse range of cuisines and dietary habits, which can contribute to digestive issues. For example, spicy and oily foods are commonly consumed in some countries, which can lead to stomach problems. As a result, there is a higher demand for remedies that specifically target these issues, such as antacids or digestive enzyme supplements.

Underlying macroeconomic factors:
The economic growth in Western Africa is also contributing to the development of the Digestive & Intestinal Remedies market. As disposable incomes increase, consumers have more purchasing power to spend on healthcare products, including digestive and intestinal remedies. Additionally, the growing middle class in the region is becoming more health-conscious, leading to an increased demand for products that promote digestive health. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Western Africa is growing due to shifting customer preferences towards natural and herbal remedies, the increasing prevalence of gastrointestinal disorders, and rising awareness about digestive health. The market is witnessing trends such as the popularity of probiotics and the availability of over-the-counter remedies. Local cultural and dietary practices, as well as the region's economic growth, are also influencing the market's development.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)